OMEROmeros Corporation
$10.72+217% 1Y
$10.72
$4.1052 weeks$21.04
Is the price fair?
What OMER's price assumes
Omeros Corporation trades at 11.1× earnings against 18.6× for the median Biotechnology name, cheaper than its own group.
11.1
Trailing P/E · Biotechnology median 18.6 · cheaper than the typical name in its group
Details›
- Healthcare median P/E509 names
- 26.0
- Biotechnology median P/E244 names
- 18.6
- Market capitalisation
- $1.38B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.